<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Tolcapone; Tasmar; Tolcapone" /><meta name="IX" content="Tasmar; Tolcapone" /><meta name="IXM" content="Tolcapone" /><title>TOLCAPONE: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3124-tolcapone.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3124-tolcapone.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3124-tolcapone.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP2092-central-nervous-system.htm">4 Central nervous system</a> &gt; <a href="PHP3054-drugs-used-in-parkinsonism-and-related-disorders.htm">4.9 Drugs used in parkinsonism and related disorders</a> &gt; <a href="PHP3056-dopaminergic-drugs-used-in-parkinsons-disease.htm">4.9.1 Dopaminergic drugs used in Parkinson's disease</a> &gt; <a href="PHP3121-catechol-o-methyltransferase-inhibitors.htm">Catechol-<em>O</em>-methyltransferase inhibitors</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3122-entacapone.htm" title="Previous: ENTACAPONE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3125-tasmar.htm#PHP3125-tasmar" title="Next: Tasmar®">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a398036.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolcapone</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Antiparkinsonian Agents 28:36 &gt; Catechol-O-Methyltransferase (COMT) Inhibitors 28:36.12</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/15928-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Tolcapone</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: T &gt; Interactions of Tolcapone</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="PHP3121-catechol-o-methyltransferase-inhibitors.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Catechol-O-methyltransferase inhibitors</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson's disease</p></div></li><li><a href="PHP3125-tasmar.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tasmar®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson's disease &gt; Catechol-O-methyltransferase inhibitors &gt; TOLCAPONE</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/15928-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolcapone</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiparkinsonian Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/09508.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolcapone</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; T &gt; TO</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-T103.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolcapone</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; T</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E2E3E0R0D858.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Tolcapone</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; T</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>TOLCAPONE</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int1042-tolcapone.htm">Tolcapone</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">adjunct to co-beneldopa or co-careldopa in Parkinson's disease with ‘end-of-dose’ motor fluctuations if another inhibitor of peripheral catechol-<em>O</em>-methyltransferase inappropriate (under specialist supervision)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">avoid abrupt withdrawal; most patients receiving more than 600 mg levodopa daily require reduction of levodopa dose by about 30%; <strong>interactions:</strong> Appendix 1 (tolcapone) </p></div> <div class="cG"><div class="cE"><h3 class="cT">Hepatotoxicity</h3> <p class="cT">Potentially life-threatening hepatotoxicity including fulminant hepatitis reported rarely, usually in women and during the first 6 months, but late-onset liver injury also reported; test liver function before treatment, and monitor every 2 weeks for first year, every 4 weeks for next 6 months and then every 8 weeks thereafter (restart monitoring schedule if dose increased); discontinue if abnormal liver function tests or symptoms of liver disorder (counselling, see below); do not re-introduce tolcapone once discontinued</p></div></div> <div class="cG"><div class="cE"><h3 class="cT">Counselling</h3> <p class="cT">Patients should be told how to recognise signs of liver disorder and advised to seek immediate medical attention if symptoms such as anorexia, nausea, vomiting, fatigue, abdominal pain, dark urine, or pruritus develop</p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">severe dyskinesia, phaeochromocytoma, previous history of neuroleptic malignant syndrome, rhabdomyolysis, or hyperthermia</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">avoid; see also under Cautions</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">caution if eGFR less than 30 mL/minute/1.73 m<sup>2</sup></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">toxicity in <em>animal</em> studies—use only if potential benefit outweighs risk</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">avoid—present in milk in <em>animal</em> studies</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">diarrhoea, constipation, dyspepsia, abdominal pain, nausea, vomiting, anorexia, xerostomia, hepatotoxicity (see above); chest pain; confusion, dystonia, dyskinesia, drowsiness, headache, dizziness, sleep disturbances, excessive dreaming, hallucinations; syncope; urine discoloration; sweating; neuroleptic malignant syndrome and rhabdomyolysis reported on dose reduction or withdrawal</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>100 mg 3 times daily, leave 6 hours between each dose; max. 200 mg 3 times daily in exceptional circumstances; first daily dose should be taken at the same time as levodopa with dopa-decarboxylase inhibitor</p></li>  </ul><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Continue beyond 3 weeks <strong>only</strong> if substantial improvement</p></div></div></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP3125-tasmar.htm#PHP3125-tasmar" title="Tasmar®">Tasmar®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3122-entacapone.htm">Previous: ENTACAPONE</a> | <a class="top" href="PHP3124-tolcapone.htm#">Top</a> | <a accesskey="]" href="PHP3125-tasmar.htm#PHP3125-tasmar" title="Tasmar®">Next: Tasmar®</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>